2020 Targeting ALK - From Discovery to Frontline Treatment
3 Visualizzazioni
• 07/30/23
0
0
Incorporare
administrator
Iscritti
In this 'keynote', Dr. Yael Mosse presents on the discovery of ALK aberrations in neuroblastoma, their significance at diagnosis and at relapse, drug development strategies and plans to incorporate ALK inhibitors into frontline therapy with potential joint COG and SIOPEN studies, and germline ALK mutation.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti